Medivir AB (publ) (STO:MVIR)
1.604
-0.106 (-6.20%)
At close: Feb 27, 2026
Medivir AB Revenue
In the year 2025, Medivir AB had annual revenue of 8.50M SEK with 143.97% growth. Medivir AB had revenue of 5.50M in the quarter ending December 31, 2025, with 522.17% growth.
Revenue
8.50M
Revenue Growth
+143.97%
P/S Ratio
101.65
Revenue / Employee
850.00K
Employees
10
Market Cap
864.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.50M | 5.02M | 143.97% |
| Dec 31, 2024 | 3.48M | -4.15M | -54.36% |
| Dec 31, 2023 | 7.63M | 3.23M | 73.16% |
| Dec 31, 2022 | 4.41M | -27.99M | -86.39% |
| Dec 31, 2021 | 32.39M | 11.96M | 58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 316.70M |
| BioInvent International AB | 226.50M |
| Genovis AB (publ.) | 129.65M |
| Oncopeptides AB | 71.12M |
| Egetis Therapeutics AB | 62.40M |
| Corline Biomedical AB | 8.59M |
| Xspray Pharma AB | 6.43M |
| FluoGuide | 318.79K |